Johnson & Johnson traded at $170.20 this Monday August 8th, decreasing $0.91 or 0.53 percent since the previous trading session. Looking back, over the last four weeks, J&J lost 4.57 percent. Over the last 12 months, its price fell by 2.02 percent. Looking ahead, we forecast Johnson & Johnson to be priced at 166.37 by the end of this quarter and at 152.92 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
170.20
Daily Change
-0.53%
Yearly
-2.02%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 140.34 2.30 1.67% 23.04%
Abiomed 293.77 2.27 0.78% -15.25%
Abbott 109.00 -0.25 -0.23% -11.17%
Amgen 247.29 1.04 0.42% 8.51%
AstraZeneca 10,758.64 44.64 0.42% 32.02%
Astrazeneca 65.12 -0.91 -1.38% 15.54%
Baxter International 59.71 1.12 1.91% -19.31%
Bayer 52.06 -0.89 -1.68% 10.09%
Becton, Dickinson and Co. 255.97 1.74 0.68% 7.27%
Biogen 217.56 -0.64 -0.29% -36.05%
Bristol-Myers Squibb 73.80 1.68 2.33% 9.53%
Boston Scientific 40.97 0.03 0.07% -6.48%
CONMED 100.51 3.50 3.61% -20.44%
Cooper Companies 333.67 2.76 0.83% -18.07%
Cardiovascular Systems 16.71 0.16 0.97% -56.05%
Dexcom 91.40 2.31 2.59% -29.36%
Edwards Lifesciences 105.46 -0.66 -0.62% -7.76%
Gilead Sciences 61.60 0.51 0.83% -11.03%
Globus Medical 63.52 0.59 0.94% -20.77%
GlaxoSmithKline 1,639.40 -20.00 -1.21% 13.37%
Hologic 72.78 1.38 1.93% -4.03%
Integra LifeSciences 55.60 -0.13 -0.23% -21.22%
Intuitive Surgical 239.13 -1.19 -0.50% -27.95%
J&J 170.20 -0.91 -0.53% -2.02%
Eli Lilly 302.50 1.18 0.39% 13.23%
Medtronic 93.58 0.30 0.32% -25.32%
Merit Medical Systems 60.68 0.74 1.23% -8.82%
Merck & Co 88.49 1.08 1.24% 17.49%
Novartis 82.64 0.36 0.44% -2.56%
NuVasive 51.86 0.39 0.76% -12.10%
Pfizer 49.57 0.30 0.61% 7.81%
Insulet 263.06 -3.99 -1.49% -8.23%
Regeneron Pharmaceuticals 630.63 17.02 2.77% 2.54%
Roche Holding 315.65 -0.20 -0.06% -13.49%
Sanofi 95.02 -1.83 -1.89% 9.76%
Stryker 217.32 1.53 0.71% -14.28%
Teva Pharmaceutical Industries Ltd 3,660.00 43.00 1.19% 12.82%
Tandem Diabetes Care 60.10 0.56 0.94% -44.19%
Vertex Pharmaceuticals 293.95 5.92 2.06% 49.62%
Zimmer Biomet Holdings Inc 113.16 -0.10 -0.09% -23.25%
Zoetis 174.01 -0.60 -0.34% -12.87%

Indexes Price Day Year
US500 4134 -5.13 -0.12% -6.81%
US30 32839 29.07 0.09% -6.88%

J&J
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism and pulmonary hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopedic, surgery, and vision fields.